| Title | Aptamers Market Opportunities, Growth and Forecasting for next Upcoming Year 2026 |
|---|
| URL | https://www.prnewswire.com/news-releases/aptamers-market-worth-342-million-by-2026--exclusive-report-by-marketsandmarkets-301415631.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Aptamers Market |
|---|
| Meta Description | DNA Aptamers Industry Size, RNA Aptamers industry Share, XNA Aptamers Market Growth, Aptamers Market Trends |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The global aptamers market in terms of revenue was estimated to be worth $151 million in 2021 and is poised to reach $342 million by 2026, growing at a CAGR of 17.7% from 2021 to 2026. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market. On the other hand, low market acceptance as compared to antibodies is likely to restrain the market growth while shortage of skilled & trained professionals may challenge market growth to a certain extent. |
